MP

Michael Pehl

CEO

ADCendo

Copenhagen, Capital Region of Denmark


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
ADCendo
Industry
research
Employees
68.0
Seniority
C suite
Annual Revenue
1300000.0
Total Funding
249524960.0
Latest Funding
Series B

Technologies

Outlook WordPress.org Mobile Friendly Google Tag Manager Google Font API Remote Basis

Keywords

biotechnology research antibody-drug conjugates adcs cancer treatment clinical trials fda clearance first-in-class therapy topoisomerase i inhibitor tissue factor clinical development oncology solid tumors optimized linker technology payload technology fda ind application patient access biotech company global health cancer research targeted therapy pharma collaboration preclinical studies trastuzumab fortified oncology mesenchymal cancers drug development safety evaluations pharmacokinetics toxicity studies monoclonal antibodies drug efficacy therapeutic innovation cancer genetic markers immunotherapy rational drug design scientific collaborations biomedical engineering patient safety biologics development clinical operations regulatory compliance medical leadership biotech financing investor relations pipeline advancement biotech innovation medical research cancer biomarkers clinical studies therapeutic modalities healthcare investments health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans